Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis

Review on the current use of antipsychotic drugs in children and adolescents

(2011) N. B. Almandil et al.   Archives of Disease in Childhood-Education and Practice Edition

Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children

(2011) Tamara Pringsheim et al.   DRUG SAFETY

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

(2011) M. De Hert et al.   EUROPEAN PSYCHIATRY

Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis

(2010) Katherine J Aitchison et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study

(2009) Magali Haas et al.   BIPOLAR DISORDERS

A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia

(2009) Magali Haas et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder

(2009) Ludmila A. Kryzhanovskaya et al.   JOURNAL OF CLINICAL PSYCHIATRY

Aripiprazole in Children and Adolescents With Bipolar Disorder Comorbid With Attention-Deficit/Hyperactivity Disorder

(2009) Silzá Tramontina et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

(2009) R. Owen et al.   PEDIATRICS

Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study

(2008) Linmarie Sikich et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia

(2008) Robert L. Findling et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia

(2008) Stefan Leucht et al.   AMERICAN JOURNAL OF PSYCHIATRY

Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial

(2008) Wendy Spettigue et al.   BMC Pediatrics

Clozapine Versus “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: An Open-Label Extension Study

(2008) Sanjiv Kumra et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Change in sexual dysfunction with aripiprazole: a switching or add-on study

(2008) Amna Mir et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Ludmila Kryzhanovskaya et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom

(2008) F. Rani et al.   PEDIATRICS

Randomized Controlled Pilot Study of Quetiapine in the Treatment of Adolescent Conduct Disorder

(2007) Daniel F. Connor et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY